What is the Position of FDA on CBD Products? 10 Important Things to Know
The use of CBD or cannabinoid is getting recognition everywhere. Several institutes across the world are now gearing up to find more beneficial properties in CBD. The use and sale of CBD are legal in many parts of the world. Sensing the significant interest of CBD among the public, the Food and Drug Administration (FDA) in the USA has decided to work on recognizing the medicinal use of CBD and the approval can help nearly 47 million seniors to improve their lives.
Today, CBD-based products are available in various formats like drugs, dietary, cosmetics, food, and animal health products. However, before coming to any conclusion, the FDA wants clear answers for some unanswered questions on the efficiency, safety, and quality of CBD-based products. Let us stress what FDA says about CBD and try to understand its resolution on this natural substance.
1 CBD for the Treatment of Seizure
The FDA has approved the use of CBD for the treatment of seizures caused by various forms of epilepsy. This is the first time when the FDA decided to recognize CBD-based drugs. The FDA has allowed the purest form of Marijuana for medicinal use and it can also improve the condition of suffering from Dravet syndrome.
2 Impact of CBD on other Medicines
The FDA has informed that CBD drug Epidiolex impacts other medications. This means if you take traditional drugs and CBD simultaneously, you can get unexpected results from both. The combination of CBD and other drugs can cause adverse effects on health.
3 Unproven CBD Products
The FDA has cautioned the people of America to be aware of unproven CBD products that can come in any form like drugs, foods, and cosmetics. Such products are marked as items unapproved by the FDA. FDA does not recognize products that are not effective for any treatment.
4 FDA is working to Evaluate Regulatory Framework
The key role of the FDA is to approve safe and effective medicines. The agency supports and encourages research and development of new medicines including the CBD-based ones. The FDA is working to evaluate the regulatory framework designed to work for cannabis-based products.
5 FDA’s Advice for Pregnant Women
FDA is against the use of CBD or cannabis-based products among pregnant or breastfeeding women. The agency has not approved any of the CBD, THC or any kind of marijuana-based products for pregnant or breastfeeding women.
FDA is ready to talk to the States that Approved the Use of Cannabis
The FDA has expressed its willingness to talk to the states that have legalized the use of CBD-based products. It has also expressed its support to the clinical research and trial of CBD-based products.
7 CBD-based Drugs and RTT
The Right to try law is designed to allow patients to try specific investigational drugs through certified physicians. The FDA, however, does not interfere in such practices. However, the drug sponsors are responsible for the effects of CBD-based products on a patient.
8 Access to CBD-based Drugs for Specific Health Conditions
Patients with serious health conditions can access CBD or cannabis-based drugs or any other medical products if there is no other alternative medicine or treatment available. The practice is called expanded access according to the FD&C Act.
9 FDA does not object to the Clinical Research of CBD or Cannabis
The FDA always supports clinical research done under the IND application that ensures whether the application of CBD-based products can improve a certain health condition or not. FDA also provides information on the method required to research under Guidance for Industry: Botanical Drug Development Act.
10 FDA’s Sound and Science-based Policies on CBD
The FDA has said that it is committed to follow a rigorous and science-based approach for all new products and innovations including products that contain CBD or any other form of cannabis.
Seniors may use CBD-based products to get relief from pain and several health conditions. The legality of the CBD-based products remains a major issue, but the ongoing research and successful experiments may open the new door of hope for people who are eagerly waiting to get CBD in their medications.
